NorthWest Biotherapeutics Inc (NWBO)

[john1045]

Northwest Biotherapeutics Inc. ($NWBO) was among the biggest gainers on the Russell 2000 for Thursday December 18 as the stock popped 5.37% to $5.69, representing a gain of $0.29 per share. Some 500,211 shares traded hands on 2,700 trades, compared with an average daily volume of 503,427 shares out of a total float of 62.22 million. The stock opened at $5.51 and traded with an intraday range of $5.72 to $5.40. After today's gains, Northwest Biotherapeutics Inc. reached a market cap of $354.02 million. Northwest Biotherapeutics Inc. has had a trading range between $10.64 and $3.20 over the last year, and it had a 50-day SMA of $5.05 and a 200-day SMA of $6.03.

Northwest Biotherapeutics Inc is a development stage biotechnology company engaged in the development of immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies. Northwest Biotherapeutics Inc. is based out of Bethesda, MD and has some 12 employees. Its CEO is Linda F Powers. For a full analysis of Northwest Biotherapeutics Inc., check out Equities.com's E.V.A. report. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index. Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000.

It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole. For more news on the financial markets, go to Equities.com. Also, learn more about our Small-Cap Stars. Register to become a member and leverage our proprietary research tools such as the Small-Cap Stars, and robust do-it-yourself Equities Valuation Analysis (E.V.A.) research reports. All data provided by QuoteMedia and was accurate as of 4:30PM ET. DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. - See more at: http://www.equities.com/editors-desk/stocks/market-movers/northwest-biotherapeutics-inc-nwbo-jumps-537-on-december-18#sthash.mYLR8rjJ.dpuf

http://www.equities.com/editors-desk/stocks/market-movers/northwest-biotherapeutics-inc-nwbo-jumps-537-on-december-18